Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Eligible female subjects will be randomly assigned to one of the three treatment groups.
Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily
during study drug treatment. The study duration is approximately six months, which is
comprised of a 4 - 6 week screening period, a three-month drug treatment period, and a
one-month follow-up period.